Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sophie Yammeni"'
Autor:
Asbjørn Due, Tobias Berg, Maj-Britt Jensen, Sophie Yammeni, Lone Volmer, Anne Sofie Brems-Eskildsen, Klaus Kaae Andersen, Saeeda Rana, Ann Knoop, Iben Kümler
Publikováno v:
Due, A, Berg, T, Jensen, M-B, Yammeni, S, Volmer, L, Brems-Eskildsen, A S, Andersen, K K, Rana, S, Knoop, A & Kümler, I 2023, ' A nationwide observational study in heavily pretreated metastatic HER2-positive breast cancer patients ', Acta Oncologica, vol. 62, no. 2, pp. 126-133 . https://doi.org/10.1080/0284186X.2023.2176257
Background: Current guidelines in HER2-positive metastatic breast cancer (mBC) recommend the combination of trastuzumab and a chemotherapeutic agent for 3rd line or later treatments. This study aims to describe the treatment of HER2-positive mBC in 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6fdae1238291c95b8c578fd876afeb8
Autor:
Stine Nyby, Signe Hertz Hansen, Sophie Yammeni, Agnieszka Monika Delekta, Gintare Naujokaite, Ursula G. Falkmer, Martin Bøgsted, Andreas Carus
Purpose: Breast cancer patients scheduled for postoperative radiotherapy undergo radiotherapy-planning computed tomography (CT), and incidental findings (IFs) may appear. This study investigated the interobserver variability between radiologists and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b26aa49a254b94214a71e01ea1c83ac2
https://doi.org/10.21203/rs.3.rs-1214703/v1
https://doi.org/10.21203/rs.3.rs-1214703/v1
Publikováno v:
British Journal of Haematology. 122:600-606
To identify patients at high risk of life-threatening infections, we retrospectively analysed the prevalence of infectious complications in 187 chronic lymphocytic leukaemia patients treated in our institution since 1999 and correlated them with clin